PROBUPHINE
Dead / Cancelled — Cancelled — Section 8 (as of 13 Oct 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86356901
- Registration number
- 5171923
- Mark type
- Design + words
- Filed
- 04 Aug 2014
- Published for opposition
- 09 Dec 2014
- Registered
- 28 Mar 2017
- Attorney of record
- Muzamil Huq
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of pain management
Owner
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 12 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jan 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Jan 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Jan 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Oct 2023 — CANCELLED SEC. 8 (6-YR)
- 28 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Dec 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Dec 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 21 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Feb 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Feb 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Feb 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE